Triple

T11466816
Position Surface form Disambiguated ID Type / Status
Subject rifampicin E271800 entity
Predicate instanceOf P0 FINISHED
Object broad-spectrum antibiotic C30876 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: broad-spectrum antibiotic
Context triple: [rifampicin, instanceOf, broad-spectrum antibiotic]
  • A. broad
    Broad refers to something that is wide in scope, range, or extent, encompassing many different aspects, ideas, or possibilities.
  • B. antimetabolite
    An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
  • C. neuraminidase inhibitor
    A neuraminidase inhibitor is an antiviral drug that blocks the activity of the viral neuraminidase enzyme, preventing the release and spread of influenza viruses from infected cells.
  • D. antineoplastic immunomodulating agent
    An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
  • E. antidote
    An antidote is a substance or treatment that counteracts or neutralizes the effects of a poison, toxin, or harmful agent in a living organism.
  • F. None of above. chosen

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aae0c8d881908a5a360c0be3242e completed April 8, 2026, 7:22 p.m.
Created at: April 8, 2026, 9:35 p.m.